• Explore /
  • Poster
  • / DOCOX: A phase II trial with docetaxel and oxaliplatin as a second-line systemic therapy for patients with advanced and/or metastatic adenocarcinoma of the pancreas.

DOCOX: A phase II trial with docetaxel and oxaliplatin as a second-line systemic therapy for patients with advanced and/or metastatic adenocarcinoma of the pancreas.

Abstract Poster

Authors

Thomas Ettrich

Thomas Jens Ettrich

Department of Internal Medicine I, University of Ulm, Ulm, Germany

Thomas Jens Ettrich , Goetz von Wichert , Thomas M. Gress , Patrick Michl , Michael Geissler , Holger Frithjof Hebart , Andreas W. Berger , Marc Porzner , Bettina Danner , Rainer Muche , Thomas Seufferlein

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT00690300

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4034)

DOI

10.1200/jco.2013.31.15_suppl.4034

Abstract #

4034

Poster Bd #

15D

Abstract Disclosures

Similar Posters

First Author: Thomas Jens Ettrich

First Author: Thomas Jens Ettrich

First Author: Choong-kun Lee

First Author: David Malka